493 related articles for article (PubMed ID: 31877923)
1. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.
Eissa MAL; Lerner L; Abdelfatah E; Shankar N; Canner JK; Hasan NM; Yaghoobi V; Huang B; Kerner Z; Takaesu F; Wolfgang C; Kwak R; Ruiz M; Tam M; Pisanic TR; Iacobuzio-Donahue CA; Hruban RH; He J; Wang TH; Wood LD; Sharma A; Ahuja N
Clin Epigenetics; 2019 Apr; 11(1):59. PubMed ID: 30953539
[TBL] [Abstract][Full Text] [Related]
3. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
[TBL] [Abstract][Full Text] [Related]
4. Novel methylation biomarker panel for the early detection of pancreatic cancer.
Yi JM; Guzzetta AA; Bailey VJ; Downing SR; Van Neste L; Chiappinelli KB; Keeley BP; Stark A; Herrera A; Wolfgang C; Pappou EP; Iacobuzio-Donahue CA; Goggins MG; Herman JG; Wang TH; Baylin SB; Ahuja N
Clin Cancer Res; 2013 Dec; 19(23):6544-6555. PubMed ID: 24088737
[TBL] [Abstract][Full Text] [Related]
5. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer.
Ying L; Sharma A; Chhoda A; Ruzgar N; Hasan N; Kwak R; Wolfgang CL; Wang TH; Kunstman JW; Salem RR; Wood LD; Iacobuzio-Donahue C; Schneider EB; Farrell JJ; Ahuja N
Pancreas; 2021 Oct; 50(9):1267-1273. PubMed ID: 34860810
[TBL] [Abstract][Full Text] [Related]
6. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
[TBL] [Abstract][Full Text] [Related]
7. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
[TBL] [Abstract][Full Text] [Related]
8. Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis.
Natale F; Vivo M; Falco G; Angrisano T
Clin Epigenetics; 2019 Sep; 11(1):132. PubMed ID: 31492175
[TBL] [Abstract][Full Text] [Related]
9. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
Ben-Ami R; Wang QL; Zhang J; Supplee JG; Fahrmann JF; Lehmann-Werman R; Brais LK; Nowak J; Yuan C; Loftus M; Babic A; Irajizad E; Davidi T; Zick A; Hubert A; Neiman D; Piyanzin S; Gal-Rosenberg O; Horn A; Shemer R; Glaser B; Boos N; Jajoo K; Lee L; Clancy TE; Rubinson DA; Ng K; Chabot JA; Kastrinos F; Kluger M; Aguirre AJ; Jänne PA; Bardeesy N; Stanger B; O'Hara MH; Till J; Maitra A; Carpenter EL; Bullock AJ; Genkinger J; Hanash SM; Paweletz CP; Dor Y; Wolpin BM
Gut; 2024 Mar; 73(4):639-648. PubMed ID: 38123998
[TBL] [Abstract][Full Text] [Related]
10. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
11. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
Syren P; Andersson R; Bauden M; Ansari D
Scand J Gastroenterol; 2017; 52(6-7):668-673. PubMed ID: 28301276
[TBL] [Abstract][Full Text] [Related]
14. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA.
Guler GD; Ning Y; Ku CJ; Phillips T; McCarthy E; Ellison CK; Bergamaschi A; Collin F; Lloyd P; Scott A; Antoine M; Wang W; Chau K; Ashworth A; Quake SR; Levy S
Nat Commun; 2020 Oct; 11(1):5270. PubMed ID: 33077732
[TBL] [Abstract][Full Text] [Related]
15. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma.
Stubbe BE; Madsen PH; Larsen AC; Krarup HB; Pedersen IS; Hansen CP; Johansen JS; Henriksen SD; Thorlacius-Ussing O
Pancreatology; 2023 Aug; 23(5):512-521. PubMed ID: 37230892
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
[TBL] [Abstract][Full Text] [Related]
19. SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis.
Mardin WA; Ntalos D; Mees ST; Spieker T; Senninger N; Haier J; Dhayat SA
Pancreas; 2016; 45(5):743-7. PubMed ID: 26646275
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
